---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-052718"
form_type: "8-K"
ticker: "CTXR"
cik: "0001506251"
company_name: "Citius Pharmaceuticals, Inc."
filed_at: "2025-06-09T23:59:59+00:00"
generated_at: "2026-05-19T17:03:32.956954+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Citius Pharmaceuticals increases authorized shares 10x, redeems Series A Preferred for $100

## Summary
- Authorized shares increased from 26M to 260M; common shares from 16M to 250M.
- Amendment approved at special meeting on June 9, 2025: 547M for, 457M against, 520K abstain.
- Series A Preferred (1B votes) automatically redeemed for $100, mirrored votes cast proportionally.
- Adjournment proposal became moot after amendment approval.

## SEC filing metadata
- accession: 0001213900-25-052718
- form_type: 8-K
- ticker: CTXR
- cik: 0001506251
- company_name: Citius Pharmaceuticals, Inc.
- filed_at: 2025-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506251/000121390025052718/0001213900-25-052718-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506251/000121390025052718/ea0245189-8k_citius.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-052718
- JSON: https://secwatch.observer/filing/0001213900-25-052718.json
- Plain text: https://secwatch.observer/filing/0001213900-25-052718.txt

## Key facts
- Governance Changes
  Citius Pharmaceuticals, Inc.: Increased authorized shares from 26,000,000 to 260,000,000 and authorized common shares from 16,000,000 to 250,000,000 (effective 2025-06-09).
  - Change: charter amendment
  - Effective: 2025-06-09
  source text: On June 9, 2025, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Secretary of State of the State of Nevada to increase the authorized shares from 26,000,000 to 260,000,000 and increase the authorized common shares, par value $0.001 per share, from 16,000,000 to 250,000,000 (the “Amendment”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506251/000121390025052718/0001213900-25-052718-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.